ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

Japan flag Japan · Delayed Price · Currency is JPY
2,294.00
-29.00 (-1.25%)
Jun 19, 2026, 3:30 PM JST
Market Cap65.14B -1.1%
Revenue (ttm)71.13B +10.9%
Net Income5.42B +6.3%
EPS191.10 +6.2%
Shares Out 28.40M
PE Ratio12.00
Forward PE11.60
Dividend65.00 (2.80%)
Ex-Dividend DateMar 30, 2026
Volume151,500
Open2,340.00
Previous Close2,323.00
Day's Range2,289.00 - 2,348.00
52-Week Range1,920.00 - 3,045.00
Beta0.45
AnalystsHold
Price Target2,500.00 (+8.98%)
Earnings DateAug 4, 2026

About TYO:4886

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also i... [Read more]

Sector Healthcare
Founded 1920
Employees 1,632
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4886
Full Company Profile

Financial Performance

In fiscal year 2026, TYO:4886's revenue was 71.13 billion, an increase of 10.90% compared to the previous year's 64.14 billion. Earnings were 5.42 billion, an increase of 6.33%.

Financial Statements